Neurogene (NGNE) Interest Coverage Ratio (2013 - 2026)
Neurogene (NGNE) posted Interest Coverage Ratio of 4.63 for Q1 2026, up 99.98% on a QoQ basis from 27529.0 in Q4 2025, and up 87.49% year-over-year from 2.47 in Q1 2025.
Neurogene (NGNE) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Neurogene's Interest Coverage Ratio history runs 13 years deep, the most recent figure standing at 4.63 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 87.49% year-over-year to 4.63 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.38 (up 88.0% YoY) and the FY2025 annual result came in at 0.74, down 2.89% from the prior year.
- Interest Coverage Ratio was 4.63 for Q1 2026 at Neurogene, up from 27529.0 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.31 in Q4 2022 and bottomed at 27529.0 in Q4 2025.
- A 5-year average of 2495.46 and a median of 37.03 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 1605958.16% — and 2024, when it soared 99.99%.
- Neurogene's Interest Coverage Ratio stood at 0.31 in 2022, then sank by 1605958.16% to 4911.0 in 2023, then soared by 99.89% to 5.56 in 2024, then slumped by 495273.55% to 27529.0 in 2025, then soared by 99.98% to 4.63 in 2026.
- Business Quant data shows NGNE's Interest Coverage Ratio at 4.63 in Q1 2026, 27529.0 in Q4 2025, and 8.21 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - | -4.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.63 |
| Dec 31, 2025 | -27,529.00 |
| Sep 30, 2025 | -8.21 |
| Jun 30, 2025 | -17.39 |
| Mar 31, 2025 | -37.03 |
| Dec 31, 2024 | -5.56 |
| Sep 30, 2024 | -1.11 |
| Jun 30, 2024 | -1.49 |
| Mar 31, 2024 | -0.58 |
| Dec 31, 2023 | -4,911.00 |
| Sep 30, 2023 | -3,804.75 |
| Jun 30, 2023 | -839.73 |
| Mar 31, 2023 | -4,345.00 |
| Dec 31, 2022 | -0.31 |
| Sep 30, 2022 | -147.92 |
| Jun 30, 2022 | -220.43 |
| Mar 31, 2022 | -548.75 |
| Dec 31, 2021 | -0.60 |
| Sep 30, 2021 | -0.84 |
| Jun 30, 2021 | -0.58 |